ABI
BKD icon

Adamant Biomedical Investments’s Brookdale Senior Living BKD Stock Holding History

Adamant Biomedical Investments’s Portfolio BKD Stock Details BKD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$4.75M Sell
129,540
-8,080
-6% -$274K 1.14% 33
2014
Q3 		$4.43M Buy
+137,620
New +$4.69M 1.11% 36

Other funds holding BKD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Adamant Biomedical Investments's BKD Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its Brookdale Senior Living (BKD) stake by 5.9% in Q4 2014, selling an estimated $274K and leaving 129,540 shares worth $4.75M. The position accounts for 1.14% of the portfolio, ranked #33.

Adamant Biomedical Investments first reported a position in BKD in Q3 2014 and has held it in 2 quarters since. 260 funds tracked by Wall St. Rank hold BKD as of Q4 2014.

  • Adamant Biomedical Investments held 129,540 shares of Brookdale Senior Living worth $4.75M as of Q4 2014.
  • Adamant Biomedical Investments sold 8,080 Brookdale Senior Living shares in Q4 2014, an estimated $274K.
  • Brookdale Senior Living made up 1.14% of Adamant Biomedical Investments's portfolio in Q4 2014, its #33 holding.
  • Adamant Biomedical Investments first reported a position in Brookdale Senior Living in Q3 2014 and has held it in 2 quarters since.
  • 260 funds tracked by Wall St. Rank held Brookdale Senior Living as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.